Selective Activation of mGlu4 Metabotropic Glutamate Receptors Is Protective against Excitotoxic Neuronal Death
- 1 September 2000
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 20 (17) , 6413-6420
- https://doi.org/10.1523/JNEUROSCI.20-17-06413.2000
Abstract
Activation of group III metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7, and mGluR8) has been established to be neuroprotectivein vitro and in vivo. To disclose the identity of the receptor subtype(s) that exert(s) the protective effect, we have used group III agonists in combination with mGluR4 subtype-deficient mice (−/−). In cortical cultures prepared from wild-type (+/+) mice and exposed to a toxic pulse of NMDA, the selective group III agonist (+)-4-phosphonophenylglycine [(+)-PPG] reversed excitotoxicity with an EC50 value of 4.9 μm, whereas its enantiomer (−)-PPG was inactive. This correlated closely with the potency of (+)-PPG in activating recombinant mGluR4a. In cortical neurons from −/− mice, (+)-PPG showed no protection against the NMDA insult up to 300 μm, whereas group I/II mGluR ligands still retained their protective activity. Classical group III agonists (l-2-amino-4-phosphonobutyrate andl-serine-O-phosphate) were also substantially neuroprotective against NMDA toxicity in +/+ and heterozygous (+/−) cultures but were inactive in −/− cultures. Interestingly, −/− cultures were more vulnerable to low concentrations of NMDA and showed higher extracellular glutamate levels compared with +/+ cultures. We have also examined neurodegeneration induced by intrastriatal infusion of NMDA in wild-type or mGluR4-deficient mice. Low doses of (R,S)-PPG (10 nmol/0.5 μl) substantially reduced NMDA toxicity in +/+ mice but were ineffective in −/− mice. Higher doses of (R,S)-PPG were neuroprotective in both strains of animals. Finally, microdialysis studies showed that intrastriatal infusion of NMDA increased extracellular glutamate levels to a greater extent in −/− than in +/+ mice, supporting the hypothesis that the mGluR4 subtype is necessary for the maintenance of the homeostasis of extracellular glutamate levels.Keywords
This publication has 37 references indexed in Scilit:
- Pharmacological characterization of an unusual mGluR-evoked neuronal hyperpolarization mediated by activation of GIRK channelsNeuropharmacology, 1999
- Activation of group III metabotropic glutamate receptors is neuroprotective in cortical culturesPublished by Elsevier ,1999
- The Role of Excitotoxicity in Neurodegenerative DiseasePharmacology & Therapeutics, 1999
- Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 receptorsPublished by Elsevier ,1999
- Cloning and characterization of alternative mRNA forms for the rat metabotropic glutamate receptors mGluR7 and mGluR8European Journal of Neuroscience, 1998
- Neuroprotection by Glial Metabotropic Glutamate Receptors Is Mediated by Transforming Growth Factor-βJournal of Neuroscience, 1998
- PHARMACOLOGY AND FUNCTIONS OF METABOTROPIC GLUTAMATE RECEPTORSAnnual Review of Pharmacology and Toxicology, 1997
- The Neuroprotective Activity of Group-II Metabotropic Glutamate Receptors Requires New Protein Synthesis and Involves a Glial–Neuronal SignalingJournal of Neuroscience, 1997
- Activation of Class II or III Metabotropic Glutamate Receptors Protects Cultured Cortical Neurons Against Excitotoxic DegenerationEuropean Journal of Neuroscience, 1995
- New Tables for Multiple Comparisons with a ControlPublished by JSTOR ,1964